Credit Agricole’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-60,000
Closed -$4.08M 1478
2017
Q1
$4.08M Hold
60,000
0.01% 798
2016
Q4
$4.3M Buy
60,000
+50,500
+532% +$3.75M 0.01% 735
2016
Q3
$752K Buy
+9,500
New +$772K ﹤0.01% 1239

Other funds holding GILD

Credit Agricole's GILD Position: Q1 2026 in Review

Credit Agricole reduced its Gilead Sciences (GILD) stake by 31% in Q1 2026, selling an estimated $40.1M and leaving 625,798 shares worth $87.2M. The position accounts for 0.23% of the portfolio, ranked #77.

Credit Agricole first reported a position in GILD in Q3 2013 and has held it in 50 quarters since. The position peaked at $195M in Q3 2014. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Credit Agricole held 625,798 shares of Gilead Sciences worth $87.2M as of Q1 2026.
  • Credit Agricole sold 286,074 Gilead Sciences shares in Q1 2026, an estimated $40.1M.
  • Gilead Sciences made up 0.23% of Credit Agricole's portfolio in Q1 2026, its #77 holding.
  • Credit Agricole first reported a position in Gilead Sciences in Q3 2013 and has held it in 50 quarters since.
  • Credit Agricole's Gilead Sciences position peaked at $195M in Q3 2014.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.